Results 201 to 210 of about 164,514 (305)

Completion vs. early discontinuation of chemotherapy and the impact on 5‐year all‐cause mortality in women treated for early‐stage breast cancer from 2015 to 2020: A cohort study using a target trial emulation approach

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Chemotherapy is given for early‐stage breast cancer; however, some patients discontinue before completing all planned cycles. This study investigated the impact of early chemotherapy discontinuation on treatment outcomes. Methods This retrospective cohort study used a target trial emulation framework to conduct a causal analysis of the all‐
Luke Steventon, Chengsheng Ju, Kenneth K. C. Man, Rebecca Roylance, Diego Ottaviani, Chiara Creed, Michal Sladkowski, Alec Wisner, Li Wei, Pinkie Chambers   +9 more
wiley   +1 more source

Association of lymph node ratio with adjuvant radiotherapy benefit in human papillomavirus-positive oropharyngeal squamous cell carcinoma: a population-based analysis. [PDF]

Infect Agent Cancer
Lu ZZ, Chen XJ, You ZQ, Li YM, Wu SG.
europepmc   +1 more source

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source

The evolution of cardiac changes after breast cancer adjuvant radiotherapy - A six-year follow-up study. [PDF]

Clin Transl Radiat Oncol
Moisander M, Tuohinen S, Lähdeaho H, Huhtala H, Nikus K, Virtanen V, Kellokumpu-Lehtinen PL, Raatikainen P, Skyttä T.   +8 more
europepmc   +1 more source

Sex-based differences in patients with locally advanced pharyngeal and laryngeal SCC treated with definitive or adjuvant radiotherapy. [PDF]

Radiat Oncol
Agolli L, Reinhard L, Gawish A, Langer C, Arens C, Krombach GA, Harth S, Wendrich L, Exeli AK, Gattenlöhner S, Adeberg S, Habermehl D.   +11 more
europepmc   +1 more source

Development and temporal validation of a machine learning-based model to predict postoperative recurrence and guide adjuvant radiotherapy in patients with soft tissue sarcoma: a retrospective cohort study. [PDF]

Am J Cancer Res
Zhao Z, Li X, Wang X, Liu X, Yuan J, Li X, Wang L, Zhang X, Liu T, Yu S.   +9 more
europepmc   +1 more source

Association of Tumor Stage and Molecular Subtype With Three-Year Recurrence Outcomes After Adjuvant Radiotherapy in Stage I-III Breast Cancer: A Single-Centre 2022 Cohort Study. [PDF]

Cureus
Nazar N, Ghumman AR, Waqar AS, Sahi MA, Ilyas A, Haider N.   +5 more
europepmc   +1 more source

Value of couch height-based positioning in postoperative adjuvant radiotherapy for left-sided breast cancer. [PDF]

Sci Rep
Shang Z, Chen J, Li M, Ge B, Feng J, Jin J, Wu J, Ji H, Chu K, Zhang X.   +9 more
europepmc   +1 more source

Multiple brain metastases: resection with IORT versus adjuvant radiotherapy and concurrent irradiation of unresected lesions. [PDF]

Radiat Oncol
Wieger G, Godó Jiménez À, Brehmer S, Etminan N, Stieler F, Giordano FA, Ruder AM.   +6 more
europepmc   +1 more source

Adjuvant radiotherapy for ypN0 breast cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis. [PDF]

Ann Surg Treat Res
Lee HS, Kim S, Kim H, Ahn KJ, Park HW, Choi Y.   +5 more
europepmc   +1 more source